Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3069-3076
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3069
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3069
Table 2 Demographic characteristics of the patients at base line
| Sodium hyaluronate | Control | P-value | |
| Age | 62.59 ± 9.23 | 62.44 ± 9.93 | 0.943 |
| Sex (male/female) | 25/12 | 26/13 | 0.933 |
| Diagnosis, n (%) | |||
| Adenocarcinoma | 5 (13.51) | 7 (17.95) | 0.869 |
| Adenoma | 31 (83.78) | 31 (79.49) | |
| Atypia | 1 (2.7) | 1 (2.56) | |
| Size (mm) | 14.2 ± 5.47 | 13.5 ± 4.35 | 0.293 |
| Location, n (%) | |||
| Antrum | 23 (62.16) | 29 (74.35) | 0.465 |
| Angle | 3 (8.10) | 3 (7.69) | |
| Body | 11 (29.72) | 7 (17.94) |
- Citation: Kim YD, Lee J, Cho JY, Kim SW, Kim SH, Cho YK, Jang JS, Han JS, Cho JY. Efficacy and safety of 0.4 percent sodium hyaluronate for endoscopic submucosal dissection of gastric neoplasms. World J Gastroenterol 2013; 19(20): 3069-3076
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3069.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3069